View Author
patient disease treatment crohn group mucosal healing study bowel therapy azathioprine healing mucosal trial fliximab remission infliximab bowel preservation score combination therapy preservation combination ni -0401 abbott response -0401 immunosuppression baseline centocor centocor ortho table point gastroenterology infusion expert panel corticosteroids level consensus result panel number expert event combination-therapy group ucb pharma university pharmaceutical surgery abbott laboratories endoscopic azathioprine group placebo combination therapy vs belgium management nejm.org lecture fees infliximab group flammatory bowel disease value medicine downloaded randomized survey immunosuppression group england journal extension corticosteroid infection netherland erasmus university infliximab monotherapy safety control pharma endoscopy ortho efficacy e ng l laboratory antibody centre
5 Most Recent Publications
|
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report
(Article)
Feagan, B.G. Lémann, M. Silverberg, M. Sorrentino, D. Woude, C.J. van der Vermeire, S. Rutgeerts, P. Befrits, R. Connell, W. D'Haens, G. Ghosh, S. Michetti, P. Ochsenkühn, T. Panaccione, R. Schreiber, S. |
2012-01-01
|
|
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease
(Article)
Woude, C.J. van der Stokkers, P.C.F. Dijkstra, G. Jong, D.J. de Oldenburg, B. Farhan, M. Richard, T. Dean, Y. Hommes, D.W. Bodegraven, A.A. van Assche, G. van Hebzda, Z. Paradowski, L. D'Haens, G. Ghosh, S. Feagan, B. Rutgeerts, P. |
2010-10-01
|
|
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease
(Article)
Dotan, I. Rachmilewitz, D. Maaser, C. Mahadevan, U. Seidler, U. Hoffman, J.C. Homoky, D. Plasse, T. Powers, B. Rutgeerts, P. Hommes, D.W. Schreiber, S. Eliakim, R. Woude, C.J. van der Kornbluth, A. Buchman, A.L. Bar-Meir, S. Bokemeyer, B. Goldin, E. |
2010-06-01
|
|
Infliximab, azathioprine, or combination therapy for Crohn's disease
(Article)
Colombel, J.F. Sandborn, W.J. Tang, K.L. Woude, C.J. van der Rutgeerts, P. Reinisch, W. Mantzaris, G.J. Kornbluth, A. Rachmilewitz, D. Lichtiger, S. D'Haens, G. Diamond, R.H. Broussard, D.L. |
2010-04-15
|
|
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
(Article)
D'Haens, G. Baert, F. Vermeire, S. Mierop, F.J. van de Coche, J.C.R. Woude, C.J. van der Ochsenkühn, T. Bodegraven, A.A. van Hootegem, P.P. van Lambrecht, G.L. Mana, F. Rutgeerts, P. Assche, G. van Feagan, B.G. Hommes, D.W. Caenepeel, P. Vergauwe, P. Tuynman, H. Vos, M. de Deventer, S. van Stitt, L. Donner, A. |
2008-02-28
|
